Jennifer Evans Stacey Insider Trading $AUXL AUXILIUM PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jennifer Evans Stacey.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jennifer Evans Stacey. Jennifer Evans Stacey is Executive VP & General Counsel in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Jennifer Evans Stacey in AUXILIUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jennifer Evans Stacey: Executive VP & General Counsel
Holdings: 16,878 shares
Latest Transaction: Apr 04 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jennifer Evans Stacey in AUXILIUM PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 04 2011 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Payment of Exercise | F | 22.47 | 941 | 21,144 | 16,878 | 17.8 K to 16.9 K (-5.28 %) |
| Feb 22 2011 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 22.04 | 40,000 | 881,600 | 40,000 | |
| Mar 16 2010 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Payment of Exercise | F | 30.20 | 941 | 28,418 | 17,819 | 18.8 K to 17.8 K (-5.02 %) |
| Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 30.20 | 35,000 | 1,057,000 | 35,000 | |
| Mar 02 2010 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Grant | A | 0.00 | 9,378 | 0 | 18,760 | 9.4 K to 18.8 K (+99.96 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 13.16 | 1,000 | 13,160 | 37,363 | |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 9.15 | 1,500 | 13,725 | 40,500 | |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 5.36 | 3,833 | 20,545 | 93,501 | |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Sell | S | 35.43 | 6,333 | 224,390 | 9,382 | 15.7 K to 9.4 K (-40.30 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 13.16 | 1,000 | 13,160 | 15,715 | 14.7 K to 15.7 K (+6.80 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 9.15 | 1,500 | 13,725 | 14,715 | 13.2 K to 14.7 K (+11.35 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 5.36 | 3,833 | 20,545 | 13,215 | 9.4 K to 13.2 K (+40.85 %) |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 13.16 | 1,000 | 13,160 | 38,363 | |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 9.15 | 1,500 | 13,725 | 42,000 | |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 5.36 | 3,833 | 20,545 | 97,334 | |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Sell | S | 32.13 | 6,333 | 203,469 | 9,382 | 15.7 K to 9.4 K (-40.30 %) |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 13.16 | 1,000 | 13,160 | 15,715 | 14.7 K to 15.7 K (+6.80 %) |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 9.15 | 1,500 | 13,725 | 14,715 | 13.2 K to 14.7 K (+11.35 %) |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 5.36 | 3,833 | 20,545 | 13,215 | 9.4 K to 13.2 K (+40.85 %) |
| Mar 03 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 32.72 | 20,000 | 654,400 | 20,000 | |
| Feb 27 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 28.50 | 30,900 | 880,650 | 30,900 | |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Payment of Exercise | F | 30.00 | 1,128 | 33,840 | 9,137 | 10.3 K to 9.1 K (-10.99 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Grant | A | 0.00 | 3,750 | 0 | 10,265 | 6.5 K to 10.3 K (+57.56 %) |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 13.16 | 637 | 8,383 | 39,363 | |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 9.15 | 1,500 | 13,725 | 43,500 | |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 5.36 | 3,833 | 20,545 | 101,167 | |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Sell | S | 30.04 | 5,970 | 179,338 | 6,515 | 12.5 K to 6.5 K (-47.82 %) |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 13.16 | 637 | 8,383 | 12,485 | 11.8 K to 12.5 K (+5.38 %) |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 9.15 | 1,500 | 13,725 | 11,848 | 10.3 K to 11.8 K (+14.50 %) |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 5.36 | 3,833 | 20,545 | 10,348 | 6.5 K to 10.3 K (+58.83 %) |
| Dec 22 2008 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 5.36 | 5,000 | 26,800 | 105,000 | |
| Dec 22 2008 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Sell | S | 27.59 | 5,000 | 137,972 | 6,515 | 11.5 K to 6.5 K (-43.42 %) |
| Dec 22 2008 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 5.36 | 5,000 | 26,800 | 11,515 | 6.5 K to 11.5 K (+76.75 %) |
| Feb 26 2008 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 32.72 | 20,000 | 654,400 | 20,000 | |
| Nov 02 2007 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 13.16 | 10,000 | 131,600 | 10,000 | |
| Feb 27 2007 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 13.16 | 40,000 | 526,400 | 40,000 | |
| Jun 08 2006 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 9.15 | 45,000 | 411,750 | 45,000 | |
| Nov 30 2005 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | P | 5.33 | 100 | 533 | 5,000 | 4.9 K to 5 K (+2.04 %) |
| Nov 30 2005 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | P | 5.31 | 4,900 | 26,029 | 4,900 | 0 to 4.9 K |
Page: 1